Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | PTPRA | P18433 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 2/20 | 0.52 |
| ▸ | MC4R | P32245 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | LCK | P06239 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26443 | 1.00 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL503312 | 1.00 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL26444 | 1.00 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| Water SCHEMBL4754409 | 0.98 | SLC7A5 (0.59) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL22285084 | 0.98 | SLC7A5 (0.59) | SLC7A5PTGS1ALPIPKMXIAP | |
| Water SCHEMBL7729304 | 0.98 | SLC7A5 (0.59) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL2724117 | 0.98 | SLC7A5 (0.59) | SLC7A5PTGS1ALPIPKMXIAP | |
| Water SCHEMBL4754408 | 0.98 | SLC7A5 (0.59) | SLC7A5PTGS1ALPIPKMXIAP | |
| Water SCHEMBL8721103 | 0.98 | SLC7A5 (0.59) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL8716271 | 0.98 | SLC7A5 (0.59) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1781310-B1 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | UNIV RAMOT (IL) | 2015-10-14 | — | — | EP | claimed |
| US-8927689-B2 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2015-01-06 | — | — | US | claimed |
| US-8796023-B2 | Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| US-20120063276-A1 | PEPTIDE NANOSTRUCTURES AND METHODS OF GENERATING AND USING THE SAME | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2012-03-15 | — | — | US | claimed |
| US-8017586-B2 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2011-09-13 | — | — | US | claimed |
| US-7786086-B2 | at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2010-08-31 | — | — | US | claimed |
| EP-1781310-A4 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | UNIV RAMOT (IL) | 2009-07-08 | — | — | EP | claimed |
| US-20090123553-A1 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-05-14 | — | — | US | claimed |
| US-20090121709-A1 | Peptide nanostructures encapsulating A foreign material and method of manufacturing same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-05-14 | — | — | US | claimed |
| US-7504383-B2 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-03-17 | — | — | US | claimed |
| US-7491699-B2 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL AVIV UNIVERSITY LTD. | 2009-02-17 | — | — | US | claimed |
| US-20080009434-A1 | at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2008-01-10 | — | — | US | claimed |
| EP-1781310-A2 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | Ramot at Tel Aviv University Ltd. (IL) | 2007-05-09 | — | — | EP | claimed |
| US-20060079455-A1 | Peptide nanostructures encapsulating a foreign material and method of manufacturing same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-04-13 | — | — | US | claimed |
| US-20060079454-A1 | Peptide nanostructures and methods of generating and using the same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-04-13 | — | — | US | claimed |
| WO-2006027780-A2 | PEPTIDE NANOSTRUCTURES CONTAINING END-CAPPING MODIFIED PEPTIDES AND METHODS OF GENERATING AND USING THE SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-03-16 | — | — | WO | claimed |
| WO-2006013552-A2 | ARTICLES OF PEPTIDE NANOSTRUCTURES AND METHOD OF FORMING THE SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-02-09 | — | — | WO | claimed |
| US-20240167062-A1 | HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-05-23 | — | — | US | disclosed |
| EP-1144368-A2 | ACETYLENIC ALPHA-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS | American Cyanamid Company (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000044709-A2 | ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240167062-A1 | HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION | HIF1A, HAO2, EGLN2 | SLC7A5 346/4885PTGS1 55/4885ALPI 4725/4885 |
| US-20080009434-A1 | at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody | DNPEP, LNPEP, ANPEP | SLC7A5 17/4885PTGS1 4835/4885ALPI 2343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.